PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.53
ESG score 80-90% of MDGL's 66.26. Walter Schloss would scrutinize governance quality and regulatory exposure.
59.54
Environmental score 80-90% of MDGL's 67.94. Walter Schloss would scrutinize carbon exposure and transition planning.
58.66
Social score 90-95% of MDGL's 62.06. Bill Ackman would demand clear social improvement catalysts.
57.40
Governance score 80-90% of MDGL's 68.79. Walter Schloss would scrutinize management accountability and board independence.